Raptor Pharmaceutical Inc. (RPTP) Reports First Quarter Calendar Year 2013 Financial Results
5/9/2013 10:13:27 AM
More...
|
Raptor Pharmaceutical Inc. (RPTP) Licenses Intellectual Property for Rett Syndrome From French Research Institutes
5/7/2013 9:35:12 AM
More...
|
Raptor Pharmaceutical Inc. (RPTP) Receives FDA Approval for Procysbi
5/1/2013 7:23:51 AM
More...
|
Raptor Pharmaceutical Inc. (RPTP) Reports Financial Results for the Transition Period From September 1, 2012 to December 31, 2012
3/15/2013 11:30:52 AM
More...
|
Raptor Pharmaceutical Inc. (RPTP) Reports First Quarter Fiscal Year 2013 Financial Results
1/10/2013 9:26:32 AM
More...
|
Raptor Pharmaceutical Inc. (RPTP) Release: HealthCare Royalty Partners Commits Over $300 Million in New Investments in December and Over $425 Million in 2012
1/3/2013 9:38:10 AM
More...
|
Raptor Pharmaceutical Inc. (RPTP) Signs $50 Million Loan Agreement With HealthCare Royalty Partners
12/20/2012 7:31:54 AM
More...
|
Raptor Pharmaceutical Inc. (RPTP) Reports Fourth Quarter and Fiscal Year 2012 Financial Results
11/14/2012 7:31:24 AM
More...
|
Raptor Pharmaceutical Inc. (RPTP) to Present at the Lazard Capital Markets 9th Annual Healthcare Conference 2012
11/12/2012 7:56:50 AM
More...
|
Raptor Pharmaceutical Inc. (RPTP) Announces Positive Data on RP103 Extension Study Presented at Kidney Week 2012
11/5/2012 9:25:56 AM
More...
|
|